bioMérieux Past Earnings Performance
Past criteria checks 4/6
bioMérieux has been growing earnings at an average annual rate of 6.3%, while the Medical Equipment industry saw earnings growing at 12% annually. Revenues have been growing at an average rate of 7.8% per year. bioMérieux's return on equity is 10.3%, and it has net margins of 10.8%.
Key information
6.3%
Earnings growth rate
6.4%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | 7.8% |
| Return on equity | 10.3% |
| Net Margin | 10.8% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How bioMérieux makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 3,807 | 411 | 1,055 | 474 |
| 31 Mar 24 | 3,741 | 384 | 1,038 | 467 |
| 31 Dec 23 | 3,675 | 358 | 1,021 | 460 |
| 30 Sep 23 | 3,688 | 372 | 1,019 | 463 |
| 30 Jun 23 | 3,701 | 386 | 1,017 | 466 |
| 31 Mar 23 | 3,645 | 419 | 986 | 456 |
| 31 Dec 22 | 3,589 | 452 | 955 | 447 |
| 30 Sep 22 | 3,525 | 502 | 916 | 429 |
| 30 Jun 22 | 3,460 | 552 | 877 | 412 |
| 31 Mar 22 | 3,418 | 577 | 846 | 399 |
| 31 Dec 21 | 3,376 | 601 | 816 | 386 |
| 30 Sep 21 | 3,296 | 555 | 801 | 381 |
| 30 Jun 21 | 3,216 | 509 | 786 | 377 |
| 31 Mar 21 | 3,167 | 457 | 788 | 388 |
| 31 Dec 20 | 3,118 | 404 | 789 | 399 |
| 30 Sep 20 | 2,997 | 355 | 784 | 399 |
| 30 Jun 20 | 2,876 | 305 | 778 | 398 |
| 31 Mar 20 | 2,775 | 289 | 764 | 386 |
| 31 Dec 19 | 2,675 | 273 | 750 | 374 |
| 30 Sep 19 | 2,601 | 268 | 721 | 362 |
| 30 Jun 19 | 2,527 | 263 | 693 | 350 |
| 31 Mar 19 | 2,474 | 260 | 668 | 338 |
| 31 Dec 18 | 2,421 | 257 | 643 | 327 |
| 30 Sep 18 | 2,372 | 264 | 626 | 320 |
| 30 Jun 18 | 2,323 | 271 | 609 | 312 |
| 31 Mar 18 | 2,306 | 255 | 607 | 308 |
| 31 Dec 17 | 2,288 | 238 | 604 | 304 |
| 30 Sep 17 | 2,262 | 216 | 604 | 300 |
| 30 Jun 17 | 2,237 | 195 | 604 | 295 |
| 31 Mar 17 | 2,170 | 187 | 587 | 283 |
| 31 Dec 16 | 2,103 | 179 | 570 | 272 |
| 30 Sep 16 | 2,068 | 158 | 555 | 260 |
| 30 Jun 16 | 2,032 | 137 | 540 | 249 |
| 31 Mar 16 | 1,998 | 124 | 534 | 244 |
| 31 Dec 15 | 1,965 | 111 | 529 | 239 |
| 30 Sep 15 | 1,908 | 127 | 510 | 230 |
| 30 Jun 15 | 1,851 | 144 | 492 | 222 |
| 31 Mar 15 | 1,775 | 140 | 472 | 214 |
| 31 Dec 14 | 1,698 | 135 | 453 | 206 |
| 30 Sep 14 | 1,656 | 135 | 437 | 201 |
| 30 Jun 14 | 1,614 | 135 | 422 | 196 |
| 31 Mar 14 | 1,601 | 150 | 413 | 191 |
| 31 Dec 13 | 1,588 | 164 | 405 | 186 |
Quality Earnings: BMXM.F has high quality earnings.
Growing Profit Margin: BMXM.F's current net profit margins (10.8%) are higher than last year (10.4%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: BMXM.F's earnings have grown by 6.3% per year over the past 5 years.
Accelerating Growth: BMXM.F's earnings growth over the past year (6.6%) exceeds its 5-year average (6.3% per year).
Earnings vs Industry: BMXM.F earnings growth over the past year (6.6%) did not outperform the Medical Equipment industry 10.4%.
Return on Equity
High ROE: BMXM.F's Return on Equity (10.3%) is considered low.